Antecedent Hematologic Disorders in AML, RAEB-t, and RAEB Groups
| . | AML . | RAEB-t . | RAEB . |
|---|---|---|---|
| . | (N = 372) . | (N = 106) . | (N = 52) . |
| Patients with AHD | 124 (33.3%) | 53 (50.0%) | 28 (53.9%) |
| Length of AHD (mo)* | |||
| Median | 5.0 | 4.0 | 5.5 |
| Mean | 18.0 | 11.3 | 6.8 |
| Range | 1-402 | 1-100 | 1-32 |
| . | AML . | RAEB-t . | RAEB . |
|---|---|---|---|
| . | (N = 372) . | (N = 106) . | (N = 52) . |
| Patients with AHD | 124 (33.3%) | 53 (50.0%) | 28 (53.9%) |
| Length of AHD (mo)* | |||
| Median | 5.0 | 4.0 | 5.5 |
| Mean | 18.0 | 11.3 | 6.8 |
| Range | 1-402 | 1-100 | 1-32 |
Among patients with AHDs.